Importance of the quotient of albumin, quotient of immunoglobulin G and Reibergram in inflammatory neurological disorders with disease‐specific patterns of blood–brain barrier permeability
- 6 January 2015
- journal article
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 3 (3) , 94-100
Abstract
Background: There are still insufficient quantitative comparisons of phase‐dependent blood–brain barrier permeability among inflammatory central nervous system disorders.Aim: By using the Reibergram (2‐D diagram of the quotient of albumin and quotient of immunoglobulin G), we visually compared the extent of blood–brain barrier permeability among inflammatory central nervous system disorders.Methods: Both the quotient of albumin and that of immunoglobulin G in the acute and chronic phase were calculated in non‐herpetic meningitis, septic meningitis, multiple sclerosis and neuromyelitis optica, and were plotted on the Reibergram. As controls, samples from non‐inflammatory patients without pleocytosis were collected. The correlation coefficient between each cerebrospinal fluid biomarker and disease severity index in each disorder was also studied.Results: In the controls, the distribution differed between males and females, suggesting a sex‐dependent difference in blood–brain barrier‐function, in addition to the age‐related compromise. A compromised blood–brain barrier was confirmed in the acute phase of meningitis and neuromyelitis optica, but not in the acute phase of multiple sclerosis. However, blood–brain barrier permeability significantly correlated with the severity and disability in multiple sclerosis. In meningitis, a compromised blood–brain barrier correlated well with the length of hospitalization rather than cerebrospinal fluid cell count.Conclusion: Visualization of the blood–brain barrier permeability with a Reibergram indicated distinct pathophysiology in each disorder. The quotient of albumin and quotient of immunoglobulin G would be useful for estimating the pathophysiology in each disorder, and the severity of ongoing inflammation or damage in the central nervous system.Keywords
This publication has 16 references indexed in Scilit:
- Cerebrospinal-fluid cytokine and chemokine profile in patients with pneumococcal and meningococcal meningitisBMC Infectious Diseases, 2013
- Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task forceEuropean Journal of Neurology, 2006
- Effects of the Chemokine CCL2 on Blood–Brain Barrier Permeability during Ischemia–Reperfusion InjuryJournal of Cerebral Blood Flow & Metabolism, 2006
- Modulating CCR2 and CCL2 at the blood–brain barrier: relevance for multiple sclerosis pathogenesisBrain, 2005
- A Guide to the Interpretation of CSF IndicesLaboratory Medicine, 2005
- IL-18: a key player in neuroinflammation and neurodegeneration?Trends in Neurosciences, 2005
- Patterns of protein expression in infectious meningitis: A cerebrospinal fluid protein array analysisJournal of Neuroimmunology, 2005
- Monocyte Chemoattractant Protein-1 Regulation of Blood–Brain Barrier PermeabilityJournal of Cerebral Blood Flow & Metabolism, 2005
- Blood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease ModelMicrocirculation, 2003
- Matrix metalloproteinases contribute to the blood—brain barrier disruption during bacterial meningitisAnnals of Neurology, 1998